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Clinical, Angiographic and Procedural Characteristics
Variable
Overall
(n¼2038)
Female
(n¼295)
Male
(n¼1743) P
Age 64.810.1 64.510.7 64.99.9 0.564
Diabetes (%) 41 46 40 0.081
Prior myocardial
infarction (%)
41 34 42 0.013
Prior coronary
artery bypass graft
surgery (%)
37 31 38 0.030
CTO Target Vessel
(%)
0.004
Right Coronary
Artery
57 62 56
Circumﬂex 21 14 22
Left Anterior
Descending
21 24 21
Technical success
(%)
88 92 87 0.040
Procedural success
(%)
87 90 86 0.053
Contrast (ml) 291.4153.2 264.3149.5 296.0153.5 0.001
Procedure time
(min)
116.963.1 101.352.0 119.364.4 <0.0001
Fluoroscopy time
(min)
44.730.6 40.226.1 45.531.2 0.003
Air Kerma radiation
exposure (Gray)
4.43.2 3.72.8 4.53.2 0.005
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMpatients underwent multislice computed tomography (MSCT) prior to the procedure.
By protocol we pre-deﬁned the same 10 anatomic characteristics by conventional
angiography (CA) and MSCT based on previously published independent predictors
of failure and our team experience. Two-experienced interventional cardiologist and
two imaging specialists, respectively, analysed CTO characteristics. Prospectively, the
Japanese-CTO score of complexity was calculated by CA and MSCT.
Results: According to the CA-Japanese-CTO score of complexity 47% of lesions
were classiﬁed as difﬁcult or very difﬁcult. By CA 52% were severe calciﬁed lesions.
In most cases (88%) the strategy was antegrade. The total stent length implanted per
lesion was of 51.6  20.3mm. In all case last generation DES was implanted. Suc-
cessful guidewire crossing was 86.4% and the overall success rate was 85.2%. Sig-
niﬁcant calciﬁcation by CA (37.5% vs. 11.5%, p ¼ 0.001) and by MSCT (> 50%
cross sectional area) (26.6% vs. 60.0%, p ¼ 0.016) was more prevalent in failed cases.
It is important to note a new anatomic characteristic “bad landing zone” (deﬁned as
distal vessel just after the CTO exit point, with reference diameter  2mm) by CA
(30.5% vs. 63.3%, p ¼ 0.01) was more prevalent in failed cases. By multivariable
logistic regression, the only independent predictor of procedural failure was the CA-J-
CTO score (odds ratio (OR) 2.5, 95% conﬁdence interval (CI) 1.37-4.59, p¼0.003, for
each unit increase in J-CTO score) and silent ischemia as baseline clinic status before
PCI-CTO (OR 4.71, CI 1.23-17.95, p¼0.02).
Conclusions: According with the results of this prospective study, the Japanese-CTO
score of complexity assessed by conventional angiograhy had a signiﬁcant impact in
procedural outcomes.
TCT-214
Procedural outcomes of CTO speciﬁc intravascular ultrasound Navifocus
WR-guided PCI for CTO
Satoshi Kameda1, Atsunori Okamura1, Motoo Date1, Hiroyuki Nagai1,
Katsuomi Iwakura1, Kenshi Fujii1
1Sakurabashi-Watanabe Hospital, Osaka, Japan
Background: At percutaneous coronary intervention (PCI) for chronic total occlusion
(CTO), the ﬁrst guidewire is sometimes inserted into the subintimal space, and in this
situation the strategy of intravascular ultrasound (IVUS)-guided wiring, that is,
leading the second guidewire into the true lumen under observing by IVUS from
subintimal space, was the last procedure because of the absence of the suitable IVUS
for this usage. Therefore we have produced CTO speciﬁc IVUS, which is named
Navifocus WR, with Terumo Corp (Tokyo, Japan). It has a small proﬁle transducer
(2.5F) with short length of tip to transducer (9mm) and will be inserted into subintimal
space with minimum vessel damage. It has been approved since September in 2012 in
Japan.
Methods: From September in 2012 to March in 2014, in 16 CTO cases, Navifocus
WR was used during the antegrade PCI approach after the ﬁrst guidewire was inserted
into the subintimal space. We succeeded the Navifocus WR-guided antegrade wiring
in 10 (63%) of 16 cases. The patients were divided into 2 groups based on the success
or failure of Navifocus WR-guided antegrade wiring.
Results: The reference diameter was larger in the success group compared to the
failure group (2.870.73 mm vs. 2.430.39 mm, P¼0.2). The procedural time of
IVUS-guided wiring was signiﬁcantly shorter in the success group compared to the
failure group (20.227.2 minutes vs. 58.541.2 minutes, P¼0.041). In the failure
group, we changed to the retrograde approach, etc. and succeeded the PCI procedure
in 15 (94%) of 16 cases.
Conclusions: At CTO PCI, the success rate of Navifocus WR-guided wiring was
acceptable and with the combination of the retrograde approach, etc the high success
rate could be achieved.
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Southwestern Medical Center, Dallas, United StatesJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/CoBackground: We sought to investigate the impact of gender on outcomes of percu-
taneous coronary intervention (PCI) for chronic total occlusions (CTO).
Methods: We examined 2,038 patients who underwent CTO PCI between January
2006 to May 2014 at 6 high volume CTO PCI centers in the United States. Clinical,
angiographic and procedural characteristics were compared between male and female
patients.
Results:Women represented 15% of the CTO PCI population. Signiﬁcant differences
were observed in the baseline characteristics of the study patients (Table). Women
were more likely to have diabetes and to have the right coronary artery as CTO target
vessel, and less likely to have prior myocardial infarction or prior coronary artery
bypass graft surgery (Table). Technical and procedural success were higher among
women, even though procedural and ﬂuoroscopy time, air kerma radiation exposure,
and contrast administration were lower among women.
Conclusions: In a large multicenter CTO PCI registry, women constituted 15% of the
patients. Technical and procedural success rates were higher among women.TCT-216
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Background: Following percutaneous coronary interventions (PCI) for revasculari-
zation of chronic total occlusions (CTO) patients are at increased risk for stent
thrombosis (ST). Delayed drug eluting stent (DES) coverage was previously shown to
be related to ST. Using optical coherence tomography (OCT) we tested the hypothesis,
that CTO-PCI is associated with delayed DES coverage compared to non-CTO
lesions.
Methods: From 06/2010 to 11/2013 105 patients (111 lesions) with clinical driven
follow-up angiography after PCI with DES received an OCT analysis. Patients with
successful CTO-PCI (19 patients/20 lesions, 6.52.1 months post-PCI) were included
into the CTO-group, patients with non-CTO lesions and total stent length >24mm (28
patients/28 lesions, 4.92.2 months post-PCI) were used as control-group.
Results: Struts were analyzed by OCT (CTO vs. control, meanSD): Covered:
68.921.9% vs. 89.610.4%, p< 0.001; uncovered apposed: 20.216.2% vs.
7.58.7%, p¼0.001; uncovered malapposed: 10.910.3% vs. 2.92.6%, p< 0.001.
Neointimal thickness was 92.061.2mm vs. 109.339.2mm, p¼0.033. No differences
concerning different CTO-PCI approaches were found.
Conclusions: A signiﬁcantly delayed DES coverage after CTO-PCI was observed.
Given the known increased rate of ST following CTO-PCI and the known associationronary Lesions - CTO B63
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.combetween delayed DES coverage and ST, OCT may aid in determining the optimal
duration of dual antiplatelet therapy after CTO-PCI.
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Background: Due to low success rates, periprocedural complications and higher
risk for restenosis the recanalization of chronic total occlusions of coronary ar-
teries (CTO) remain a challenging task in interventional cardiology. Furthermore
several studies have revealed that restenosis and late stent thrombosis are linked to
the polymer layer of drug eluting stents. We therefore tested whether drug eluting
stents with completely biodegradable polymers are applicable for the treatment of
CTO’s.
Methods: In order to test this hypothesis we retrospectively examined in a mono-
centric analysis data of 102 CTO patients who were exclusively treated with biolimus
eluting stents with fully biodegradable polymers in the past 24 months. CTO was
deﬁned as total occlusion of a coronary artery for more than 3 months and TIMI 0 ﬂow
in the occluded segment. Primary study endpoint was late loss at the initial occlusion
site after 6 months. Secondary clinical endpoints included a composite of cardiac
death, myocardial infarction and target vessel revascularization after 6 months
(MACE).
Results: 170 CTO procedures were performed in the past 24 months. 138 CTO’s
were successfully reopened which corresponded to a success rate of 81%. The mean
occlusion length of 24  14 mm was treated with an average stent length of 68  30
mm. J-CTO score was 1,8  0,9. 102 of the successfully recanalized CTO patients
received biolimus eluting stents with biodegradable polymers. Meanwhile 78 pa-
tients have concluded angiographic and clinical 6 months follow up. Late loss at the
initial occlusion site was 0,26  0,56 mm. Binary restenosis with the need for
reintervention occurred only in 5 patients (6,4%). Cardiac death was documented in
1 patient. In addition to that, one patient suffered from a stent thrombosis with a
consecutive myocardial infarction during follow up. Therefore the MACE rate was
calculated with 9%.
Conclusions: First results of our monocentric analysis indicate that biolimus eluting
stents with fully biodegradable polymers are associated with little late loss and low
MACE rates in complex CTO lesions. Future studies in larger, independent patient
cohorts are necessary to conﬁrm our results.
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Background: Clinical beneﬁt in improving procedural success of a multi-slice
computed tomography (MSCT) analysis prior to CTO recanalization is unknown. We
performed a prospective randomized trial so as to assess clinical impact of MSCT in
improving immediate procedural results.
Methods: 106 eligible patients who were scheduled for percutaneous recanalization of
a true CTO (Euro-CTO deﬁnition) and without contraindications for MSCT were
included in the study (TACCTO). All patients underwent MSCT and were randomized
(1:1) to be or not to be aware of the result of the MSCT prior to CTO recanalization.
MSCT versus conventional coronary angiography (CCA) group were compared
regarding immediate procedural success. By protocol, same 10 CTO CCA and MSCT-
angiography characteristics (based on previously published independent predictors of
CTO failure) were pre-deﬁned to be independently analysed. In the MSCT group, CT-
scan analysis was open to the operator prior to the procedure. A 256-detector system
was used for all studies. Post processing was performed with speciﬁc software.
Results: The mean age was 62  10 years old. According to the Japanese-CTO score
of complexity 51% of lesions were classiﬁed as difﬁcult or very difﬁcult. 52% were
calciﬁed lesions and RCA was the most frequent lesion treated. In most cases (88%)
the strategy was anterograde. The total stent length implanted per lesion was of 51.6
20.3mm. In all case last generation DES was implanted. Technical success was
achieved in 86.8% of the patients in the MSCT group and 84.9% of those in the CCA
group (p¼0.75). According to the J-CTO score 2 subgroups of complexity were done:
a) easy-intermediate and b) difﬁcult-very difﬁcult. In sub-group a), procedural success
was achieved in 100% in both groups (MSCT and CCA). In sub-group b), procedural
success was achieved in 80% of the patients in the MSCT group and 75.7% of those in
the CCA group (p¼0.85).
Conclusions: According with the results of this prospective randomized trial, in our
current era, with new CTO material and techniques, it seems that the information
provided by MSCT could be useful, but did not provide a signiﬁcant impact in pro-
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Background: This study sought to investigate predictive factors of ﬁnal PCI proce-
dural success in patients with LAD-CTO compared to patients with nLAD-CTO
Methods: A total of 1,657 patients who underwent 1,819 CTO-PCI at ICPS between
January 2004 and December 2013 were included in the study. Clinical, angiographic,
technical, procedural characteristics and adverse events occurring within 24 hrs were
prospectively collected. Procedural success was deﬁned as a ﬁnal diameter stenosis <
30% and TIMI ﬂow 3. Predictors of PCI success in LAD-CTO vs nLAD-CTO, were
analyzed by univariable and multivariable analysis. Early (< 24 hrs) events were recorded.
Results: The overall procedural success rate was 72.4%. Of 1,819 procedures, 542
(29.7%) were LAD-CTO-PCI. LAD-CTO-PCI had a higher procedural success rate
compared to nLAD (78.8% vs 69.7%, p< 0.0001). By logistic regression analysis,
including clinical and angiographic variables, severe CTO calciﬁcation (OR 0.46,
95%CI 0.24-0.87; nLAD: 0.35, 95%CI 0.23-0.52) , lesion length 20 mm (OR 0.55,
95%CI 0.35-0.87; nLAD OR 0.45, 95%CI 0.35-0.58), previous CABG (OR 0.1, 95%
CI 0.04-0.27; OR 0.61, 95%CI 0.40-0.93) and previous MI (0.58 95%CI 0.34-0.96;
nLAD: OR 0.69, 95%CI 0.5-0.93) were associated with a lower procedural success
rate both in LAD and in nLAD subgroups. Lesion tortuosity was an independent
predictor of PCI failure exclusively in the LAD-CTO group (OR 0.41 95%CI 0.18-
0.93), while a blunt morphology was independently correlated to lower procedural
success in the nLAD-CTO group (OR 0.58, 95%CI 0.44-0.75). No differences in
terms of death, myocardial infarction and urgent pericardiocentesis within 24 hours
were recorded between the two groups.
Conclusions: Both in the LAD-CTO-PCI and nLAD-CTO-PCI subgroup, severe
CTO calciﬁcation, lesion length, previous CABG and previous MI were predictors of
procedural success. Interestingly, lesion tortuosity and blunt stump were indepen-
dently correlated to lower procedural success in the LAD-CTO and in the nLAD-CTO
subgroup, respectively.
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Background: The aim of the present study was to evaluate the effect of chronic total
occlusion (CTO) localization in nonifarct-related artery (IRA) on 12 months mortality in
patients with NSTEMI and multivessel coronary artery disease (MV CAD) treated with PCI
Methods: We analyzed consecutive records of 991 patients with NSTEMI and MV
CAD treated with PCI admitted to the Clinic between 2006 and 2011. The inclusion
criteria were presence of MV CAD, single CTO in non-IRA and availability of 12-
month follow up. Patients with a history or qualiﬁed to CABG during current hos-
pitalization were excluded from further analysis. Clinical characteristics, in-hospital
and 12-month outcomes of 165 patients were analyzed according to localization of
CTO in coronary angiography. Patients were divided into three groups: CTO in left
anterior descending artery (CTO LAD n¼43), CTO in left circumﬂex (CTO LCx
n¼47), CTO in right coronary artery (CTO RCA n¼75).
Results: In baseline characteristic we observed signiﬁcant differences in occurrence of
diabetes (respectively: 53,5% vs 31,9% vs 25,3 p¼0,007). In-hospital mortality was
signiﬁcantly higher in CTO RCA group (respectively:2.3% vs 0.0% vs 9.3%
p¼0.044). The rates of myocardial re-infarction, target vessel revascularization,
stroke, major bleeding and average GRACE score during the hospitalization were
similar in all analyzed groups. CTO in RCA was associated with increased 12 months
mortality in studied groups (respectively: 13.9% vs 4.3 % vs 22.7% p¼0.022), post
hoc analysis showed signiﬁcant difference between CTO RCA and CTO LCx groups
(P¼0,006). In multivariate analysis CTO localized in RCA remained independent
factor inﬂuencing 12 month mortality (HR: 3,82; 95%CI: 1,58-9,20; p:< 0,003).
Conclusions: In studied population localization of CTO in RCA was associated with
worse clinical outcomes and was an independent predictor of 12 month mortalityj September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
